Presentation of 9M Figures BRAIN AG
|
|
- Ilene Riley
- 6 years ago
- Views:
Transcription
1 Presentation of 9M Figures BRAIN AG BRAIN Key Enabler for a Biobased Economy Zwingenberg, August 31, 2016 BRAIN Aktiengesellschaft Zwingenberg Germany (0)
2 Disclaimer This document may contain forward-looking statements. These forward-looking statements are subject to risks and uncertainties, as they relate to future events and are based on current assumptions of the Company, which may not occur at all in the future or may not occur as assumed. They do not represent a guarantee for future results or performance of the Company, and the development of economic and legal conditions may materially differ from the information expressed or implied in the forward-looking statements. The Company assumes no obligation to update or revise any forward-looking statement contained herein or to adapt them to future events or developments. The information contained in this document has not been independently verified. No representation or warranty expressed or implied is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of the information or opinion contained herein. The Company or any of its shareholders, affiliates, advisors, employees or representatives shall have no liability whatsoever (in negligence or otherwise) for any loss arising from any use of this document or its content or otherwise arising in connection with this document. By accepting this presentation you acknowledge that you will be solely responsible for your own assessment of the market and the market position of the Company and that you will conduct your own analysis and be solely responsibility for forming your own view of the potential future performance of the Company s business. This presentation speaks as of August 31, Neither the delivery of this presentation nor any further discussions of the Company with any of the recipients shall, under any circumstances, create any implication that there has been no change in the affairs of the Company since such date. BRAIN Aktiengesellschaft Zwingenberg Germany (0)
3 Speakers Dr. Jürgen Eck (CEO) Dr. Georg Kellinghusen (CFO) Eric Marks (COO) Micro- & Molecular Biologist 53 years Co-founded BRAIN in y of industry expertise Well connected in industry Management & Strategy R&D, IP and Technology Master of Business Adminstration 68 years Joined BRAIN in y of experience as CFO in 4 listed companies Finance, Accounting Controlling Compliance & IR Industrial Engineer, Business Economist 54 years Joined BRAIN in y of expertise in industrial enzymes Track record with industry leaders Sales, Business Operations Strategic & Innovation Management BRAIN Aktiengesellschaft Zwingenberg Germany (0)
4 Our mission: Enabling BioEconomy We discover and produce novel biological ingredients on the basis of our proprietary BioArchive for the improvement of product applications in multiple B2B markets. We enable sustainable, efficient and bio-based products & processes in the speciality and consumer goods segments of the chemical industry. We are on our way to become a fully integrated bio-speciality company. BRAIN Aktiengesellschaft Zwingenberg Germany (0)
5 Significant Events 9M 2015/16 Important milestone reached in the strategic partnership with DIANA Pet Food Already in the first year an initial milestone in understanding taste function in cats was reached and proliferating cat taste cells (CTCs) were achieved faster than planned BRAIN and Südzucker AG are intensifying their cooperation in the field of microbial utilization of carbon dioxide The two partners enter into scale-up to a pilot facility at the Südzucker CO 2 -emitting plant in Zeitz BRAIN accelerates biotechnology production process optimisation Under the successfully started alliance NatLifE 2020 BRAIN is working together with PS Biotech GmbH on optimizing biofermentation production processes expecting time savings of 30% compared to the conventional timelines BRAIN Aktiengesellschaft Zwingenberg Germany (0)
6 Financial Highlights BRAIN Aktiengesellschaft Zwingenberg Germany (0)
7 BRAIN Group Financial Highlights 9M 2015/16 BRAIN Group generated a total operating performance of Euro 19.0m (9M 2014/15: Euro 19.8m) Revenues increased to Euro 16.5m (9M 2014/15: Euro 16.1m) Further expansion of BioScience segment based on growing collaboration business with international industrial partners reaching 9.1 million in 9M period (+ 5% YOY) In 9M period BioIndustrial segment accounted for Euro 10.0m (9M 2014/15: Euro 11.2m) The Group EBIT amounted to Euro -7.7m (9M 2014/15: Euro -3.9m) Adjusted by IPO costs of Euro 1.1m and adjusted by personnel expenses resulting from a sharebased compensation scheme at Analyticon of Euro 1.3m The adjusted EBIT amounted to Euro -5.2m (9M 2014/15: Euro -3.7m) Euro -4.9m related to the BioScience segment and Euro -0.3m related to the BioIndustrial segment BRAIN will continue to pursue its course of profitable growth From today's perspective BRAIN expects to reach EBIT break-even as planned in fiscal year 2017/18 BRAIN Aktiengesellschaft Zwingenberg Germany (0)
8 Key Quarterly Financials 9M FY 2015/16 (in Euro million) 1 9M 9M 2015/ /15 Total operating performance BioScience BioIndustrial Adjustments (consolidation effects) EBIT Adjusted EBIT Group result Result per share (in Euro) Cash flows from operating activities Cash flows from investing activities Cash flows from financing activities ) The financial figures of the first nine months of fiscal year 2015/16 are comparable only to a limited extent to the values of the previous year, as for the first nine months of FY 2014/15 they include the financial figures of the WeissBioTech organisations only since November 2014 due to the acqusition 2) Revenues + change in inventories + other income including R&D grants, only comparable to a limited extent 3) Adjusted for one-off costs of the IPO and expenses resulting from share-based employee participation plans BRAIN Aktiengesellschaft Zwingenberg Germany (0)
9 Financials Total Operating Performance by Segments 1) 2) (in m) Total Operating Performance 9M 1) 2) 4) (in m) BioScience BioIndustrial /12A 2012/13A 2013/14A 2014/15A 2014/15 9M 2015/16 9M EBIT (in m) 2011/12A 2012/13A 2013/14A 2014/15A 2014/15 9M³ /16 9M³ ) Total operating performance = revenues + change in inventories + other operating income 2) w/o intersegment elimination of c 0.2m in FY12/13, FY13/14 and FY14/15 3) Adjusted EBIT 4) The financial figures of the first nine months of fiscal 2015/16 are comparable only to a limited extent to the value sof the previous year, as for the first nine months of FY 2014/15 they include the financial figures of the WeissBioTech organisations only since November 2014 due to the acqusition BRAIN Aktiengesellschaft Zwingenberg Germany (0)
10 Business Highlights BRAIN Aktiengesellschaft Zwingenberg Germany (0)
11 BRAIN Group BioIndustrial - Highlights 9M 2015/16 Within the segment BioIndustrial our emphasis on the more profitable specialty enzymes business continues to deliver results. While the global market weakness of bulk enzymes for bioethanol production continues, several customers have increased production again, resulting in a recovery of the enzyme sales. In total the segment generated Euro 10.0m revenues. In Q3 2015/16 a new product was launched, the new Serie Monteil ProBeActive. This product is a probiotic, activating Anti-Aging treatment created on the basis of the lactic acid bacterium Lactococcus lactis. The use of this natural active compound is a first in the global cosmetics industry. BRAIN Aktiengesellschaft Zwingenberg Germany (0)
12 BRAIN Group BioScience - Highlights 9M 2015/16 Further expansion of BioScience segment based on growing collaboration business with international industrial partners reaching 9.1 million in 9M period (+ 5% YOY). Important milestone reached in the strategic partnership with DIANA Pet Food. Already in the first year an initial milestone in understanding taste function in cats was reached and proliferating cat taste cells (CTCs) were achieved faster than planned. The CTC technology is derived from BRAIN s proprietary Human Taste Cell Technology (HTC) enabling to screen for bioactive natural substances to improve foodstuff preparations. BRAIN and Südzucker AG are intensifying their cooperation in the field of microbial utilization of carbon dioxide. The two partners enter into scale-up to a pilot facility at the Südzucker CO 2 -emitting plant in Zeitz. Based on producer microorganisms developed by BRAIN the partnership makes use of CO 2 as a feedstock for the production of intermediate products including monocarboxylic and dicarboxylic acids for bioplastics. BRAIN to accelerate biotechnology production process optimisation. Under the successfully started alliance NatLifE 2020 BRAIN receives funding of the German Federal Ministry of Education and Research (BMBF). As part of this alliance, BRAIN is working together with PS Biotech GmbH on optimizing biofermentation production processes expecting time savings of 30% compared to the conventional timelines. BRAIN Aktiengesellschaft Zwingenberg Germany (0)
13 Events after the end of the quarter US patent granted for new generation of taste cell technology. On 2 August 2016, BRAIN received the US patents to utilise taste bud technology for screening purposes. The company has developed this technology on the basis of human taste buds, resulting in Human Taste Cell lines enabling high-throughput screening programs for the identification of natural substances for novel food formulations which improve taste and also help reduce calorie and salt content. 'DOLCE' strategic industrial partnership to develop new generation of biological sugar substitutes. One focus of BRAIN new product development portfolio lies on the development of biological sweeteners. On 29 August, BRAIN AG, AnalytiCon Discovery GmbH as part of the BRAIN Group, and Roquette S. A. (Roquette) a market leader in intermediate products for the food manufacturing industry agreed a strategic partnership to develop a new generation of natural sweeteners and sweet flavour enhancers. Negotiations with two major consumer goods manufacturers concerning participating in "DOLCE" advanced further in Q3 2015/16. Additional consumer goods manufacturers have been invited to join the industrial partnership in various foodstuff markets and participate in the partnership's innovations. BRAIN Aktiengesellschaft Zwingenberg Germany (0)
14 DOLCE Consortium new sweet solutions for industry World market leading food manufacturing and converting industry BRAIN Aktiengesellschaft Zwingenberg Germany (0)
15 Financial Calendar August 31, 2016 Publication of the quarterly report for the period ending 30 June 2016 (9M) December 20, 2016 Publication of the annual report for the period ending 30 September 2016 (12M) February 28, 2017 Publication of the quarterly report for the period ending 31 December 2016 (3M) March 2017 Annual General Meeting BRAIN Aktiengesellschaft Zwingenberg Germany (0)
16 Thank you for your interest. BRAIN Aktiengesellschaft Darmstädter Straße Zwingenberg +49 (0) Your Contact: Investor Relations Dr. Martin Langer +49 (0) BRAIN Aktiengesellschaft Zwingenberg Germany (0)
Presentation of 6M Figures BRAIN AG
Presentation of 6M Figures BRAIN AG BRAIN Key Enabler for a Biobased Economy Zwingenberg, May 31, 2016 BRAIN Aktiengesellschaft Zwingenberg Germany www.brain-biotech.de +49 (0) 6251-9331-0 Disclaimer This
More informationEngineering Biology. BRAIN Key Enabler for a Biobased Economy. Corporate Presentation. Zwingenberg, October 26, Engineering Biology.
BRAIN Key Enabler for a Biobased Economy Corporate Presentation Zwingenberg, October 26, 2017 BRAIN Aktiengesellschaft Zwingenberg Germany www.brain-biotech.de +49 (0) 6251-9331-0 Disclaimer This document
More informationPRESS RELEASE. BRAIN AG granted patent protection for the development of biological compounds used in antiperspirants and deodorants
PRESS RELEASE Cosmetics based on bio-active ingredients BRAIN AG granted patent protection for the development of biological compounds used in antiperspirants and deodorants US patent rights for novel
More informationPRESS RELEASE. New efficient detergent enzymes from the metagenome start of another cooperation between BRAIN AG and Henkel KGaA
PRESS RELEASE New efficient detergent enzymes from the metagenome start of another cooperation between BRAIN AG and Henkel KGaA Zwingenberg, Düsseldorf (Germany), February 2005 The german biotech company
More informationThe main goal of the strategic partnership is the development of innovative, all-natural cosmetic active ingredients and aroma molecules.
PRESS RELEASE Symrise: Strategic partnership with BRAIN and AnalytiCon Discovery (Holzminden/Potsdam/Zwingenberg, April 2, 2007) Symrise GmbH & Co. KG, the world s fourth-largest supplier of fragrance
More informationXING AG. Dr. Stefan Gross-Selbeck (CEO) & Ingo Chu (CFO) Hamburg, May 12, 2010
Q1 Results Presentation XING AG Dr. Stefan Gross-Selbeck (CEO) & Ingo Chu (CFO) Hamburg, May 12, 2010 01 Starting Position Recap from FY 2009 results presentation... 2010: The year of profitable growth...
More informationSoftware AG announces offer for IDS Scheer
Software AG announces offer for IDS Scheer Analyst Presentation Karl-Heinz Streibich, CEO Arnd Zinnhardt, CFO July 14, 2009 Forward Looking Statement The information contained in this presentation has
More informationINVESTOR PRESENTATION
INVESTOR PRESENTATION SWISS EQUITIES CONFERENCE BAADER HELVEA R. ERNI, CFO BAD RAGAZ 12 JANUARY 2018 Panalpina Biz Model / Strategy Achievements and key figures Operating and financial review Appendix
More informationThird quarter results 2018
1 Third quarter results 2018 25 October 2018 Peter A. Ruzicka, President & CEO Disclaimer This presentation has been prepared by Orkla ASA (the Company ) solely for information purposes. The presentation
More informationFIRST QUARTER RESULTS 2016 INVESTOR PRESENTATION
FIRST QUARTER RESULTS 2016 INVESTOR PRESENTATION THREE MONTH RESULTS 21 APRIL 2016 Highlights and key figures Operating and financial review Outlook and priorities Appendix FIRST QUARTER RESULTS 21 APRIL
More informationAnnual General Meeting Review of Management Board Remuneration May 8, 2014
Annual General Meeting Review of Management Board Remuneration May 8, 2014 Cautionary Note 2 THIS DOCUMENT IS BEING PROVIDED TO YOU SOLELY FOR YOUR INFORMATION BY AMG ADVANCED METALLURGICAL GROUP N.V.
More informationRESULTS JANUARY JUNE 2008 ANALYST CONFERENCE CALL
RESULTS JANUARY JUNE 2008 ANALYST CONFERENCE CALL 14 AUGUST 2008 Hamburger Hafen und Logistik AG DISCLAIMER The facts and information contained herein are as up to date as is reasonably possible and are
More informationSunrise Communications Group AG. Olaf Swantee
Sunrise Communications Group AG Olaf Swantee Agenda 1 First impressions 2 Q2 16 Summary 4 Conclusion 5 Q&A 2 Strong 1 st impressions - solid base to build on for the future Innovative products via diversified
More informationCommercial and technology day -Insight into a dynamic industry. 11 November 2011
Commercial and technology day -Insight into a dynamic industry 11 November 2011 Agenda Day overview and context Debbie Millar Group Executive: Treasury, IR and funding Commercial Overview Christian de
More informationThorn Brand - Strategy Update
Thorn Brand - Strategy Update Capital Markets Day 2012 Martin Brandt, COO Zumtobel Group 1 1 A brief portrait of Thorn Lighting People Thorn is the oldest brand in the Zumtobel Group Founded in 1928 in
More informationSTRATEGIC UPDATE 20 DECEMBER 2017
STRATEGIC UPDATE 20 DECEMBER 2017 DISCLAIMER - This presentation is intended to constitute a summary of certain information about Synlait Milk Limited ( Synlait ). It should be read in conjunction with,
More informationGRUPO ANTENA 3 FY11 RESULTS. February 23rd, 2012
GRUPO ANTENA 3 FY11 RESULTS February 23rd, 2012 www.grupoantena3.com Highlights Total Ad market declined by -7% in 2011, with TV down -10% and Radio - 5% yoy Antena 3 outperformed the market, just -1%
More informationPiper Jaffray Clean Technology & Renewables Conference. Samuel Yang, Chief Executive Officer
Piper Jaffray Clean Technology & Renewables Conference Samuel Yang, Chief Executive Officer February 20, 2008 Disclaimer This presentation does not constitute an offer to sell or issue or the solicitation
More informationAbcam Plc. JP Morgan Healthcare Conference January 2017
Abcam Plc JP Morgan Healthcare Conference January 2017 2 Disclaimer Important information The information provided in this presentation is for the sole use of those attending the presentation; it shall
More informationHAMBURGER HAFEN UND LOGISTIK AG COMPANY PRESENTATION
HAMBURGER HAFEN UND LOGISTIK AG COMPANY PRESENTATION UNICREDIT GERMAN INVESTMENT CONFERENCE MUNICH, SEPTEMBER 2010 Hamburger Hafen und Logistik AG DISCLAIMER The facts and information contained herein
More information4904 (TWSE) Q Investor Update. Disclaimer. Yvonne Li President
1 494 (TWSE) 214 1Q Investor Update Yvonne Li President 2 Disclaimer This presentation contains forward-looking statements. These forward-looking statements are subject to risks, uncertainties and assumptions,
More informationBRAIN AG Annual Report 2017/18. BRAIN networks
BRAIN networks Networks dynamize value added Technology-driven innovation cycles are becoming shorter and shorter. This is concurrent with rapidly changing consumer wishes. Sustainable production and the
More informationHAMBURGER HAFEN UND LOGISTIK AG COMPANY PRESENTATION
HAMBURGER HAFEN UND LOGISTIK AG COMPANY PRESENTATION CHEUVREUX GERMAN CORPORATE CONFERENCE FRANKFURT, 20 JANUARY 2010 Hamburger Hafen und Logistik AG DISCLAIMER The facts and information contained herein
More informationGRUPO ANTENA 3 FY12 RESULTS. February 28th,
GRUPO ANTENA 3 FY12 RESULTS February 28th, 2013 www.grupoantena3.com FY12 Highlights According to our estimates, Total Ad market declined by -16% in 2012 (TV and Radio down by -19% and -14% yoy respectively)
More informationPHOTOCURE ASA RESULTS FOR SECOND QUARTER AND FIRST HALF YEAR August 2018
PHOTOCURE ASA RESULTS FOR SECOND QUARTER AND FIRST HALF YEAR 2018 8 August 2018 Erik Dahl, CFO and Interim CEO Ambaw Bellete, President, Photocure Inc. and Head, US Cancer Commercial Operations DISCLAIMER
More informationStrengthening the experience and embracing the shift
Strengthening the experience and embracing the shift THIS PRESENTATION IS NOT AN OFFER OR SOLICITATION OF AN OFFER TO BUY OR SELL SECURITIES. IT IS SOLELY FOR USE AT A CAPITAL MARKETS EVENT AND IS PROVIDED
More informationH&M group capital markets day Stockholm 2018 H&M GROUP CAPITAL MARKETS DAY 2018
H&M group capital markets day Stockholm 2018 Disclaimer THIS PRESENTATION IS NOT AN OFFER OR SOLICITATION OF AN OFFER TO BUY OR SELL SECURITIES. IT IS SOLELY FOR USE AT A CAPITAL MARKETS EVENT AND IS PROVIDED
More informationSociété Générale, USA, May 13 th -15 th RTL Group
Société Générale, USA, May 13 th -15 th 2015 RTL Group Agenda 1 2 3 4 2015 5 Quarter 1 2015 highlights Group financials Business segments Outlook 2015 Strategy update 2 1 2 3 4 5 Highlights Successful
More informationCapital Markets Day 2013 Contract Logistics. Detlef Trefzger Chief Executive Officer, Kuehne + Nagel International AG September 18, 2013
Capital Markets Day 2013 Contract Logistics Detlef Trefzger Chief Executive Officer, Kuehne + Nagel International AG September 18, 2013 Stagnating Revenue and Margins Over the Last Years 5000 4500 4000
More informationFor personal use only
The Future of TV is Personal Linius patented Video Virtualization Engine is designed to convert cumbersome, legacy video into interactive, virtual video, enabling Artificial Intelligence, personalization,
More informationPresentation for Deutsche Bank Swiss Equities Conference
Zurich Airport, 19 th May 2010 Monika Ribar, CEO Presentation for Deutsche Bank Swiss Equities Conference 19 th May 2010 2 Panalpina at a glance Comprehensive global network Among top 5 globally in air
More informationMacquarie Securities Conference Australia
Macquarie Securities Conference Australia Greg Hunt Managing director and chief executive officer Wednesday, 3 May 2017 Disclaimer General This presentation has been prepared by Nufarm Limited. The information
More informationI n t e r i m R e p o r t
I n t e r i m R e p o r t F i n a n c i a l Y e a r 2 0 0 7 / 0 8 1. Quarter 1 March to 31 May 2007 Mannheim, 12 July 2007 First quarter at a glance Revenues up 10.8% to 34.1 (30.8) 1) million Operating
More informationQ1 17 Revenue. Michel Denis, President & CEO Hervé Rochet, Chief Financial Officer
Q1 17 Revenue Michel Denis, President & CEO Hervé Rochet, Chief Financial Officer Q1 2017 Revenue I April 20, 2017 1 Disclaimer This presentation includes only summary information and does not in any way
More informationIntraSoft Technologies Limited
IntraSoft Technologies Limited Investor Presentation 28 th May, 2018 BSE: 533181, NSE: ISFT ` Lakhs Revenue Continues To Grow Above Industry Rates 40000 35000 33826 30000 25000 20000 15000 12255 10116
More informationDELIVERING SUSTAINED AND PROFITABLE GROWTH. Karim Michel Sabbagh, President and CEO
DELIVERING SUSTAINED AND PROFITABLE GROWTH Karim Michel Sabbagh, President and CEO World s Leading Satellite-enabled Solutions Provider Covering 99.99% of the globe and world s population Serving customers
More informationFor personal use only
Go to View / Master / Slide Master. Insert, position and crop pictures on this Master Slide behind Vision Graphic element. MASTERMYNE GROUP AGM OPERATIONS UPDATE NOVEMBER 2017 www.mastermyne.com.au Overview
More informationFor personal use only. KNeoMedia Limited (ASX:KNM) Annual General Meeting 2016 Presentation
For personal use only KNeoMedia Limited (ASX:KNM) Annual General Meeting 2016 Presentation Worldwide revenues for games-based learning reached $2.6b in 2016. The global CAGR is a robust 22.4%. Revenues
More informationHIKMA PHARMACEUTICALS PLC. Merrill Lynch Middle East & North Africa (MENA) Conference 13 December r 2005
HIKMA PHARMACEUTICALS PLC Merrill Lynch Middle East & North Africa (MENA) Conference 13 December r 2005 Important notice This document and its contents are confidential and may not be redistributed or
More informationCEO of CTC Media since August Graduate of Moscow Finance Institute and London School of Economics
MTG Capital Markets Day June 10, 2010 Anton Kudryashov Chief Executive Officer Anton Kudryashov: Background CEO of CTC Media since August 2008 Graduate of Moscow Finance Institute and London School of
More informationDOING BUSINESS IN CHINA 27 OCTOBER 2017
DOING BUSINESS IN CHINA 27 OCTOBER 2017 DISCLAIMER - This presentation is intended to constitute a summary of certain information about Synlait Milk Limited (Synlait). It should be read in conjunction
More informationAFC Energy plc AGM Presentation. 25 April 2017
AFC Energy plc AGM Presentation 25 April 2017 1 Disclaimer This presentation has been prepared by AFC Energy plc (the Company ). By attending this presentation and/or reviewing the slides you agree to
More informationTalend Investor Relations Presentation November 2017
Talend Investor Relations Presentation November 2017 2017 Talend SA 1 This presentation and the accompanying oral presentation contain forward-looking statements. All statements other than statements of
More informationBiotechnology-Derived Plant Products
GUIDE FOR Product Launch OF Biotechnology-Derived Plant Products 1 Disclaimer The Guide for Product Launch Stewardship of Biotechnology-Derived Plant Products ( Guide ) is solely an educational tool and
More informationFor personal use only
ASX Release Apiam Animal Health Limited (ASX: AHX) Investor Presentation Melbourne, 2 July, 2018 Apiam Animal Health Limited today releases the attached Investor Presentation, which provides an update
More informationAccelerating Fish Growth
Accelerating Fish Growth Nissim Chen Ph.D., M.B.A., Founder & CEO September 2017 1 Legal Disclaimer IMPORTANT NOTICE This presentation has been prepared by AquiNovo Ltd. (the Company ) solely for informational
More informationPHOTOCURE ASA NORTH-AMERICAN LIFE SCIENCE CONFERENCE. New York, 29 November Daniel Schneider, President and CEO
PHOTOCURE ASA NORTH-AMERICAN LIFE SCIENCE CONFERENCE New York, 29 November 2018 Daniel Schneider, President and CEO DISCLAIMER By reading this company presentation (the Presentation ), or attending any
More informationDisclaimer. 2
www.valirx.com 1 Disclaimer This Document comprises an institutional presentation (the Presentation ) which has been prepared by and is the sole responsibility of ValiRx plc (the Company ). The content
More informationInvestor Presentation. 2 nd Quarter 2017
Investor Presentation 2 nd Quarter 2017 1 1 Disclaimer This document has been prepared by Mobily (the Company ) solely for presentation purposes. The information contained in this document has not been
More informationFY18 Results. Mark Coulter CEO Mark Tayler CFO
FY18 Results Mark Coulter CEO Mark Tayler CFO Page 1 Contents CEO Update Page 3-15 FY18 Financial Results Page 16-20 Strategy & Outlook Page 21 24 Q&A Page 2 CEO Update Mark Coulter CEO Pg 26 Page 3 Summary
More informationQ Revenue Release
Q3 2007 Revenue Release Olivier Piou, CEO Jacques Tierny, CFO November 8, 2007 www.gemalto.com Disclaimer Forward-Looking Statements This communication contains certain statements that are neither reported
More informationFor personal use only. copyright Quickstep Holdings. All Rights Reserved.
copyright 2015. Quickstep Holdings. All Rights Reserved. Disclaimer» This Presentation is provided by Quickstep Holdings Limited ( Quickstep or the Company ) as a summary of the Company and its operations
More informationInitiation of Project STAR July 28, 2016
Initiation of Project STAR July 28, 2016 Disclaimer This document has been issued by windeln.de AG (the Company ) and does not constitute or form part of and should not be construed as any offer or invitation
More informationSQID Technologies Ltd
SQID Technologies Ltd Optimizing the way business wants to make payments Simple and flexible in a single solution. This is a briefing to shareholders of SQID Technologies Limited. This information session
More informationIndustry - Biobased Innovations in Manufacturing. Global BioEconomy Summit 19 April 2018 Karl-Heinz Maurer, AB Enzymes GmbH
Industry - Biobased Innovations in Manufacturing Global BioEconomy Summit 19 April 2018 Karl-Heinz Maurer, AB Enzymes GmbH What is the IWBio? Industry driven network 19 small, medium and large enterprises
More informationPreliminary Results January September 2014
Creating the Leading Digital Telco Preliminary Results January September 2014 November 10, 2014 Disclaimer This document contains statements that constitute forward-looking statements and expectations
More information18,000+ ACTIVE USERS. AGM PRESENTATION November 2017 $600M+ TRANSACTION VALUE
18,000+ ACTIVE USERS AGM PRESENTATION November 2017 $600M+ TRANSACTION VALUE A Leading Payment Solutions & Technology Partner In Asia-Pacific SOUTH EAST ASIA 2 Our Markets $120B Singapore retail & online
More informationFor personal use only 18,000+ ACTIVE USERS $600M+ TRANSACTION VALUE. AGM PRESENTATION November 2017
18,000+ ACTIVE USERS AGM PRESENTATION November 2017 $600M+ TRANSACTION VALUE A Leading Payment Solutions & Technology Partner In Asia-Pacific SOUTH EAST ASIA 2 Our Markets $120B Singapore retail & online
More informationReorganisation & Revised Segmental Reporting. November 2016
Reorganisation & Revised Segmental Reporting November 2016 Disclaimer This document has been prepared by the Company solely for purpose of communicating the change to the Company s Segmental Reporting
More informationFor personal use only. Chair s Address Professor Andrew Vizard Chairman 24 November 2016
Chair s Address Professor Andrew Vizard Chairman 24 November 2016 Disclaimer DISCLAIMER The information presented to you by Apiam Animal Health Limited ACN 604 961 024 (Company) in this presentation and
More information& Creating the UK s leading food business
& Creating the UK s leading food business This merger is about unlocking new growth. Tesco, the UK s leading retailer, and Booker, the UK s leading food wholesaler, are merging to form what can become
More informationDigitalizing the Fashion Supply Chain. Modtissimo Workshop: How to increase business as a garment manufacturer by using digital tools
Digitalizing the Fashion Supply Chain Modtissimo 2018 Workshop: How to increase business as a garment manufacturer by using digital tools 26.09.2018 v14 Agenda Why the traditional way is obsolete Digital
More informationAnnual General Meeting 27 October, 2011
Annual General Meeting 27 October, 2011 MediVac Limited. a: P.O.Box 656 Baulkham Hills NSW 1755 p: +61 2 9912 5100 w: www.medivac.com.au e: paul.mcpherson@medivac.com.au Our Mission To build shareholder
More information1QFY2017 Results Presentation
1QFY2017 Results Presentation China Everbright Water Limited May 2017 Forward-looking statements This presentation may contain forward-looking statements. Any such forward-looking statements are based
More informationRosneft the Leader of the Russian Oil Industry. Eduard Khudainatov President of Rosneft New York, April 18, 2012
Rosneft the Leader of the Russian Oil Industry Eduard Khudainatov President of Rosneft New York, April 18, 2012 Post-IPO Dynamics (2006-2011) Reserve replacement Well above the industry average Discovery
More informationSQS India BFSI Investors Presentation
SQS the world s leading specialist in software quality SQS the world s leading specialist in software quality sqs.com Sqs-bfsi.com SQS India BFSI Investors Presentation Dr. Martin Müller Managing Director
More informationHOLIDAYCHECK GROUP COMPANY PRESENTATION
HOLIDAYCHECK GROUP COMPANY PRESENTATION Agenda 1 2 3 4 5 Who we are Drivers of growth Financials Outlook Appendix 2 Who we are 3 Our vision We are the most Urlauber*-friendly company in the world! We make
More informationGRUPO ANTENA 3. Presentation to investors Global Telecom & Media Conf. Bank of America Merrill Lynch. May
GRUPO ANTENA 3 Presentation to investors 2012 Global Telecom & Media Conf. Bank of America Merrill Lynch May 2012 www.grupoantena3.com Antena 3 Group at a glance Antena 3 Group One of the largest communication
More informationBluechiip Ltd (ASX:BCT)
Bluechiip Ltd (ASX:BCT) Annual General Meeting, Nov 2016 Andrew McLellan Managing Director Unique patented MEMS technology combining secure wireless tracking with integrated temperature sensing for extreme
More informationGoldman Sachs Internet Conference Las Vegas, NV. May 21, 2008
Goldman Sachs Internet Conference Las Vegas, NV May 21, 2008 Disclaimer These presentation materials have been prepared by Gmarket Inc. ( Gmarket or the Company ) and have not been independently verified.
More informationSPHERIX ANNOUNCES 2009 FINANCIAL RESULTS
SPHERIX Investor Relations Phone: (301) 897-2564 Email: info@spherix.com SPHERIX ANNOUNCES 2009 FINANCIAL RESULTS BETHESDA, MD, April 1, 2010 - Spherix Incorporated (NASDAQ CM: SPEX), an innovator in biotechnology
More informationFY16 AGM Rob Woolley, Chair Laura McBain, CEO 19 October 2016
FY16 AGM Rob Woolley, Chair Laura McBain, CEO 19 October 2016 SHARE PRICE $ 18 16 14 12 10 8 6 4 2 0 05-Aug-14 30-Aug-14 30-Sep-14 31-Oct-14 30-Nov-14 31-Dec-14 31-Jan-15 28-Feb-15 31-Mar-15 30-Apr-15
More informationDisciplined Growth From Back-to-Basics Focus
Disciplined Growth From Back-to-Basics Focus Stephan DuCharme, CEO X5 Capital Markets Day 2014 Moscow, Russian Federation 29 October 2014 X5 RETAIL GROUP INTRODUCTION 2 CURRENT X5 CONTEXT Effective multi-format
More informationFor personal use only
Strategy Update TrafficGuard SaaS August 2018 Mathew Ratty Chief Executive Officer 1 Disclaimer This presentation contains summary information about Tech Mpire Limited (Tech Mpire) and is current as at
More informationGermany Global Customer Reference Program
Activities Germany Global Activities Global SAP BELIEVES YOU OUR CUSTOMER TELL OUR STORY BEST Your experience as a technology leader is an important source of information to us, and also to our entire
More information2018 Q2 Investor Presentation. August 2018
2018 Q2 Investor Presentation August 2018 NOTICE This presentation does not constitute an offer or invitation to purchase or subscription for any securities and no part of it shall form the basis of or
More informationTalend Investor Relations Presentation August 25, 2016
Talend Investor Relations Presentation August 25, 2016 2016 Talend SA 1 This presentation and the accompanying oral presentation contain forward-looking statements. All statements other than statements
More informationMetabolix, Inc. (NASDAQ:MBLX) Investor Presentation
Metabolix, Inc. (NASDAQ:MBLX) Investor Presentation Focused on Yield10 Bioscience as the Core Business Third Quarter Financial Results and Business Update November 9, 2016 Safe Harbor Statement* The statements
More informationSunrise Communications AG. Sunrise ONE versus Swisscom inone - High level comparison
unrise Communications AG unrise ONE versus wisscom inone - High level comparison unrise ONE - Everything unlimited aunch andline & obile in ONE package New fully convergent high-end product, complementing
More informationOur passion is to deliver sustainable value to our customers 2008 First Half Results 23 July 2008
Our passion is to deliver sustainable value to our customers 2008 First Half Results 23 July 2008 Stefan Borgas Chief Executive Officer Disclaimer Certain matters discussed in this presentation may constitute
More informationDEZ 2016 LEADING CLOUD TRANSFORMATION PARTNER
DEZ 2016 LEADING CLOUD TRANSFORMATION PARTNER FORWARD LOOKING STATEMENTS & DISCLAIMER This presentation contains forward-looking statements that are subject to risks, uncertainties and assumptions. The
More informationFULL YEAR 2017 RESULTS PRESENTATION
FULL YEAR 2017 RESULTS PRESENTATION February 27 th 2018 Juan Lladó CEO 1 DISCLAIMER This document has been prepared by Técnicas Reunidas S.A. (the Company) solely for use at presentations held in connection
More informationINNOVATING SES S TECHNOLOGY SOLUTIONS. Martin Halliwell, Chief Technology Officer
INNOVATING SES S TECHNOLOGY SOLUTIONS Martin Halliwell, Chief Technology Officer Innovating SES s Technology Solutions Expanding flexibility and scalability of SES s global network and capabilities Delivering
More informationEVOTEC REPORTS FIRST QUARTER 2018 RESULTS AND PROVIDES CORPORATE UPDATE
, 09 MAY 2018 EVOTEC REPORTS FIRST QUARTER 2018 RESULTS AND PROVIDES CORPORATE UPDATE 55% INCREASE IN GROUP REVENUES STRONG UNDERLYING OPERATIONAL PERFORMANCE WITH NEW BUSINESS MIX AFTER APTUIT ACQUISITION
More informationaap Implantate AG Corporate Presentation German Equity Forum 2018 Bruke Seyoum Alemu, CEO Marek Hahn, CFO
aap Implantate AG Corporate Presentation German Equity Forum 2018 Making Trauma Treatment Better and Cost-Effective Bruke Seyoum Alemu, CEO Marek Hahn, CFO Frankfurt am Main, November 27, 2018 Safe Harbor
More informationAccessing advanced TIDVAL technology at cost in return for sharing the up-side
HORIZON DISCOVERY Accessing advanced TIDVAL technology at cost in return for sharing the up-side On Helix, Cambridge UK, July 2015 Jon Moore CSO Disclaimer This Presentation does not constitute or form
More informationQ4 & FY 2018 Results Conference Call April 1, 2019
Q4 & FY 2018 Results Conference Call April 1, 2019 Safe Harbor Statement This presentation contains certain forward-looking statements that are based upon current expectations and involve certain risks
More informationWirecard AG Results 1 st quarter of fiscal 2013 Investor Presentation
Wirecard AG Results 1 st quarter of fiscal 2013 Investor Presentation Aschheim, May 16 2013 2013 Wirecard AG 1 Content 1. Key Figures / Highlights 1st quarter of fiscal 2013 2. Products and Solutions 3.
More informationMolecular Partners launches IPO on SIX Swiss Exchange
For release in Switzerland only. This is a restricted communication and you must not forward it or its contents to any person to whom forwarding it is prohibited by the legends contained therein. In particular,
More informationRecommended acquisition of The BSS Group plc. 5 July 2010
Recommended acquisition of The BSS Group plc 5 July 2010 Important information This document is being made available only to persons who fall within the exemptions contained in Article 19 and Article 49
More informationResults Q May 2010
Results Q1 2010 12 May 2010 Q1 Highlights Subscription revenues up 20.2% year on year Gross additions up 10.1% year on year 12 months rolling churn rate down 1.4 points year on year; quarterly annualized
More informationMorgan Stanley Global Consumer Conference
Morgan Stanley Global Consumer Conference Ralph Edmondson, Head of Investor Relations New York - November 2011 Important information This presentation has been prepared by British American Tobacco p.l.c.
More informationIndium facility at the Auby smelter
Indium facility at the Auby smelter 20 September 2012 Xavier Constant Technology Manager, Auby smelter Important Notice This presentation has been prepared by the management of Nyrstar NV (the "Company").
More informationANALYST DAY November 30, 2016
ANALYST DAY November 30, 2016 Run-down: - Smithfield North Plant tour - Innovation Center tour and product tasting - Supermarket tour - Presentation and Q&A Management: Ken Sullivan (CEO), GLENN Nunziata(CFO),
More informationElectronics Limited. Inve. Results Presentation Q3 FY16
Electronics Limited Inve Results Presentation Q3 FY16 Safe Harbor This presentation has been prepared by Salzer Electronics Limited (the Company ) solely for information purposes and does not constitute
More informationAgenda. 1 Financial Highlights. 2 Financial Review. 3 Customer Review. 4 Business Review
IPPC V.01 Disclaimer This presentation has been prepared by Comba Telecom Systems Holdings Limited (the Company ) for reference only. The information contained in this presentation has not been independently
More informationYield10 Bioscience, Inc.
Yield10 Bioscience, Inc. (NASDAQCM:YTEN) Investor Presentation Yield10 is developing new technologies to achieve step-changes in crop yield to enhance global food security November 2018 Safe Harbor Statement*
More informationCollagen Solutions Plc
Collagen Solutions Plc Jamal Rushdy, CEO Growth & Innovation Forum 2017 January 2017 Disclaimer This presentation is incomplete without reference to, and should be viewed solely in conjunction with the
More informationSK Networks H
SK Networks 2017. 1H 01 Disclaimers This material has been produced by SK Networks Co., Ltd. solely for information purposes. The information contained in this document has not been independently verified.
More information